Does pharmacotherapy influence the inflammatory responses during cardiopulmonary bypass in children?

Area of Science:

• Pediatric surgery
• Anesthesiology
• Immunology

Background:

• Cardiopulmonary bypass (CPB) initiates a systemic inflammatory response syndrome (SIRS).
• SIRS involves complex inflammatory and anti-inflammatory responses post-CPB.
• Factors like blood-surface contact and hypothermia contribute to SIRS during CPB.

Purpose of the Study:

• To review the pathophysiology of SIRS and counter-anti-inflammatory response syndrome in pediatric CPB.
• To analyze the influence of anesthetic and extracorporeal circuit drugs on these inflammatory responses.
• To highlight potential benefits of tailored pharmacotherapy for improved outcomes.

Main Methods:

• Literature review of studies on CPB, SIRS, and pharmacotherapy in pediatric patients.
• Analysis of the mechanisms underlying inflammatory responses during and after CPB.
• Synthesis of current knowledge on drug effects on SIRS and CARS.

Main Results:

• CPB triggers SIRS through multiple factors including foreign surface contact and hypothermia.
• Postoperative SIRS is modulated by a counter anti-inflammatory response syndrome.
• Preoperative and intraoperative drug administration significantly impacts these inflammatory pathways.

Conclusions:

• Understanding CPB-induced inflammation is crucial for pediatric surgical recovery.
• Pharmacotherapy can modulate SIRS and CARS, offering potential for personalized treatment.
• Further research into drug effects may lead to improved patient outcomes and economic benefits.